Paroxetine Mesylate: Multi-Target Mechanisms and Translation
2026-06-02
Explore the multi-faceted actions of Paroxetine Mesylate, a leading selective serotonin reuptake inhibitor, in psychiatric, oncology, and neurocardiac research. This article offers a unique, mechanistic analysis and practical insights, setting it apart from prior SSRI and biomarker coverage.
Atrial Natriuretic Peptide (ANP), Rat: Systems Biology Insig
2026-06-02
Explore the multifaceted roles of Atrial Natriuretic Peptide in cardiovascular research. This article uniquely integrates systems biology, mechanistic insights, and protocol recommendations for the advanced use of ANP peptide hormone.
Lisinopril dihydrate: ACE Inhibitor Benchmarks for Research
2026-06-01
Lisinopril dihydrate is a long-acting ACE inhibitor widely used in hypertension, heart failure, and nephropathy research. Its high selectivity and reproducibility make it a gold standard for renin-angiotensin system modeling. This article details its mechanism, validated applications, limitations, and optimized research workflows.
Phenylmethanesulfonyl Fluoride: Precision in Protease Inhibi
2026-06-01
Phenylmethanesulfonyl fluoride (PMSF) delivers unmatched specificity for irreversible serine protease inhibition, making it indispensable in protein extraction and Western blot sample preparation. Explore how APExBIO’s PMSF streamlines workflows, safeguards sample integrity, and addresses advanced troubleshooting in sensitive cellular and developmental biology assays.
Propidium Iodide: DNA Intercalating Dye for Advanced Cell An
2026-05-31
Propidium iodide (PI) stands apart as a DNA intercalating dye, enabling precise cell viability, apoptosis, and cell cycle assays. With robust fluorescence and membrane selectivity, PI empowers researchers to discriminate between healthy and compromised cells—even in complex immunological or infection models.
Reliable Lab Assays with Minocycline HCl (SKU B1791): Data-D
2026-05-30
This article addresses key workflow and interpretive challenges in cell-based assays, providing scenario-driven guidance for biomedical researchers and lab technicians. Leveraging evidence and protocol insights, we show how Minocycline HCl (SKU B1791) from APExBIO enables reproducible, sensitive, and workflow-compatible solutions for viability, proliferation, and cytotoxicity assays.
S63845 MCL1 Inhibitor: Precision Apoptosis Activation in Can
2026-05-29
Harnessing the selectivity of S63845, researchers can dissect mitochondrial apoptosis in resistant hematological and solid tumors with unprecedented accuracy. This guide details experimental workflows, combinatorial strategies, and troubleshooting tactics to maximize S63845's potential in apoptosis-focused cancer research.
ABT-263 (Navitoclax): Expanding Senescence and Apoptosis Res
2026-05-29
Explore how ABT-263 (Navitoclax) is redefining the boundaries of apoptosis and senescence research in cancer biology. This article uniquely bridges Bcl-2 inhibition with insights from recent senotherapeutic advances, offering advanced guidance for translational and assay-focused scientists.
LDH Cytotoxicity Assay Kit: Reliable Cell Damage Quantificat
2026-05-28
The LDH Cytotoxicity Assay Kit enables precise, non-radioactive cell cytotoxicity measurement by quantifying lactate dehydrogenase release with high sensitivity. Its robust workflow supports apoptosis detection in diverse research settings, representing a safer alternative to traditional radioactive assays.
Polybrene (Hexadimethrine Bromide): Precision in Viral Gene
2026-05-28
Polybrene (Hexadimethrine Bromide) 10 mg/mL by APExBIO redefines viral transduction, elevating gene delivery efficiency in even difficult-to-transfect cell lines. Its versatility as a lipid-mediated DNA transfection enhancer and anti-heparin reagent positions it as an essential tool in advanced molecular workflows.
Myriocin Modulates dAGE-Induced Metabolic Dysfunction via AM
2026-05-27
This study demonstrates that myriocin, a potent serine palmitoyltransferase inhibitor, reverses obesity and metabolic disturbances caused by dietary advanced glycation end products (dAGEs) in mice. The work uncovers a novel mechanistic link between sphingolipid inhibition, AMPK-PGC1α signaling, and mitochondrial activation, with broad implications for metabolic disease research.
TBK1 Inhibition Alleviates Painful Diabetic Neuropathy via M
2026-05-27
Liao et al. (2024) reveal that TANK-binding kinase 1 (TBK1) drives microglial pyroptosis and hyperalgesia in painful diabetic neuropathy (PDN), with TBK1 inhibition—via siRNA or amlexanox—significantly reducing neuropathic symptoms in mouse models. Their mechanistic study offers new insight into the inflammatory underpinnings of PDN and points to TBK1 as a potential therapeutic target.
Doxycycline as a Precision Tool for 3D Cell Mechanotransduct
2026-05-26
Explore how Doxycycline, a tetracycline antibiotic, enables advanced mechanotransduction studies in three-dimensional hydrogel models. This in-depth review connects antiproliferative and metalloproteinase-inhibitory properties to the latest stem cell differentiation assays, offering unique insights for cancer research and tissue engineering.
Thiothixene: Typical Antipsychotic Agent for Efferocytosis E
2026-05-26
Thiothixene is a typical antipsychotic agent that not only targets central dopamine D2 and serotonin 5-HT2A receptors but also enhances macrophage efferocytosis via the vitamin A signaling pathway. This dual mechanism underlies its established role in schizophrenia therapy and its emerging applications in immunological research. Recent evidence demonstrates its ability to induce Arginase 1 and Stra6l, promoting continual efferocytosis in vitro and in vivo.
HDAC Inhibition Disrupts NUT Carcinoma Oncogenic Transcripti
2026-05-25
Shiota et al. identified structurally diverse histone deacetylase (HDAC) inhibitors as potent repressors of NUT function in NUT carcinoma, using a high-throughput chemical screen. Their findings define a mechanistic link between HDAC inhibition and disruption of BRD4-NUT-driven oncogenic transcription, suggesting therapeutic potential for this aggressive cancer.
466 records 17/32 page Previous Next First page 上5页 1617181920 下5页 Last page